SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 2,444.62 |
Enterprise Value ($M) | 1,913.94 |
Book Value ($M) | 532.84 |
Book Value / Share | 13.15 |
Price / Book | 4.59 |
NCAV ($M) | 505.61 |
NCAV / Share | 12.48 |
Price / NCAV | 4.83 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.33 |
Return on Assets (ROA) | -0.56 |
Return on Equity (ROE) | -0.61 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 19.03 |
Current Ratio | 19.03 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 552.05 |
Assets | 579.27 |
Liabilities | 46.44 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Alkeon Capital Management Llc | 5.00 | 7.65 | |
13G/A | Fmr Llc | 12.93 | 5.30 | |
13G/A | BlackRock, Inc. | 6.80 | 24.32 | |
13D/A | Orbimed Advisors Llc | 4.20 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
128,494 | 439,778 | 29.22 | |
85,601 | 509,379 | 16.80 | |
37,612 | 278,286 | 13.52 | |
86,857 | 481,794 | 18.03 | |
(click for more detail) |
Similar Companies | |
---|---|
KALV – KalVista Pharmaceuticals, Inc. | KLTO – Klotho Neurosciences, Inc. |
KOD – Kodiak Sciences Inc. | KYMR – Kymera Therapeutics, Inc. |
LBPH – Longboard Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io